We have demonstrated that selected inflammatory and anti-inflammatory markers (CRP, adiponectin, leptin, resistin, and Lp-PLA2) are involved in both pathogenesis of metabolic syndrome and pathogenesis of psoriasis. The gene discussed is ADIPOQ; the disease is metabolic syndrome.